{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:21:31Z","timestamp":1793388091853,"version":"4.5.0"},"reference-count":293,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","award":["IG\/AGR\/FOOD\/17\/02"],"award-info":[{"award-number":["IG\/AGR\/FOOD\/17\/02"]}],"id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12640-018-9989-9","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T02:17:38Z","timestamp":1547173058000},"page":"739-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Protective Effects of Antioxidants in Huntington\u2019s Disease: an Extensive Review"],"prefix":"10.1007","volume":"35","author":[{"given":"Musthafa Mohamed","family":"Essa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Moghadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Ba-Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Walid Qoronfleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamilarasan","family":"Manivasagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arokiasamy","family":"Justin-Thenmozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipul","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravana Babu","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-Joon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"9989_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3109\/09553002.2010.501844","volume":"86","author":"AA Abd-El-Fattah","year":"2010","unstructured":"Abd-El-Fattah AA, El-Sawalhi MM, Rashed ER, El-Ghazaly MA (2010) Possible role of vitamin E, coenzyme Q10 and rutin in protection against cerebral ischemia\/reperfusion injury in irradiated rats. Int J Radiat Bio 86:1070\u20131078. https:\/\/doi.org\/10.3109\/09553002.2010.501844","journal-title":"Int J Radiat Bio"},{"key":"9989_CR2","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1093\/hmg\/ddv099","volume":"24","author":"M Achour","year":"2015","unstructured":"Achour M, Le Gras S, Keime C, Parmentier F, Lejeune FX, Boutillier AL, N\u00e9ri C, Davidson I, Merienne K (2015) Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington\u2019s disease mice. Hum Mol Genet 24:3481\u20133496. https:\/\/doi.org\/10.1093\/hmg\/ddv099","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9989_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1086\/301846","volume":"62","author":"ACMG\/ASHG statement","year":"1998","unstructured":"ACMG\/ASHG statement (1998) Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics\/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet 62(5):1243\u20131247","journal-title":"Am J Hum Genet"},{"key":"9989_CR4","doi-asserted-by":"publisher","unstructured":"Acu\u00f1a AI, Esparza M, Kramm C, Beltr\u00e1n FA, Parra AV, Cepeda C, Toro CA, Vidal RL, Hetz C, Concha II, Brauchi S, Levine MS, Castro MA (2013) A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice. Nat Commun 4:2917. https:\/\/doi.org\/10.1038\/ncomms3917","DOI":"10.1038\/ncomms3917"},{"key":"9989_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/ars.2009.2668","volume":"12","author":"RM Adibhatla","year":"2010","unstructured":"Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12:125\u2013169. https:\/\/doi.org\/10.1089\/ars.2009.2668","journal-title":"Antioxid Redox Signal"},{"key":"9989_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.410310412","volume":"31","author":"RL Albin","year":"1992","unstructured":"Albin RL, Reiner A, Anderson KD, Dure LS, Handelin B, Balfour R, Whetsell WO, Penney JB, Young AB (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease. Ann Neurol 31:425\u2013430. https:\/\/doi.org\/10.1002\/ana.410310412","journal-title":"Ann Neurol"},{"key":"9989_CR7","first-page":"84","volume":"49","author":"PN Aleksandrov","year":"1986","unstructured":"Aleksandrov PN, Speranskaia TV, Bobkov IG, Zagorevski\u012d VA, Zykov DA (1986) Effect of rutin and esculamine on models of aseptic inflammation. Farmakol Toksikol 49:84\u201386","journal-title":"Farmakol Toksikol"},{"issue":"11","key":"9989_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00001756-199808030-00001","volume":"9","author":"T Alexi","year":"1998","unstructured":"Alexi T, Hughes PE, Faull RL, Williams CE (1998) 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9(11):57\u201364","journal-title":"Neuroreport"},{"key":"9989_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","volume":"16","author":"VM Andr\u00e9","year":"2010","unstructured":"Andr\u00e9 VM, Cepeda C, Levine MS (2010) Dopamine and glutamate in Huntington\u2019s disease: a balancing act. CNS Neurosci Ther 16:163\u2013178. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00134.x","journal-title":"CNS Neurosci Ther"},{"key":"9989_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","volume":"8","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF (2001) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease. Neurobiol Dis 8:479\u2013491","journal-title":"Neurobiol Dis"},{"key":"9989_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S1357-4310(98)01371-9","volume":"4","author":"TC Andrews","year":"1998","unstructured":"Andrews TC, Brooks DJ (1998) Advances in the understanding of early Huntington\u2019s disease using the functional imaging techniques of PET and SPET. Mol Med Today 4:532\u2013539","journal-title":"Mol Med Today"},{"key":"9989_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2013.01.007","volume":"701","author":"E Antunes Wilhelm","year":"2013","unstructured":"Antunes Wilhelm E, Ricardo Jesse C, Folharini Bortolatto C, Wayne Nogueira C (2013) Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington\u2019s disease: protective effect of melatonin. Eur J Pharmacol 701:65\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.007","journal-title":"Eur J Pharmacol"},{"key":"9989_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/14734220601142878","volume":"6","author":"M Arakawa","year":"2007","unstructured":"Arakawa M, Ito Y (2007) N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 6:308\u2013314. https:\/\/doi.org\/10.1080\/14734220601142878","journal-title":"Cerebellum"},{"key":"9989_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jnr.10272","volume":"68","author":"MA Ariano","year":"2002","unstructured":"Ariano MA, Aronin N, Difiglia M, Tagle DA, Sibley DR, Leavitt BR, Hayden MR, Levine MS (2002) Striatal neurochemical changes in transgenic models of Huntington\u2019s disease. J Neurosci Res 68:716\u2013729. https:\/\/doi.org\/10.1002\/jnr.10272","journal-title":"J Neurosci Res"},{"key":"9989_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/15548627.2014.996021","volume":"11","author":"G Ashrafi","year":"2015","unstructured":"Ashrafi G, Schwarz TL (2015) PINK1- and PARK2-mediated local mitophagy in distal neuronal axons. Autophagy 11:187\u2013189. https:\/\/doi.org\/10.1080\/15548627.2014.996021","journal-title":"Autophagy"},{"key":"9989_CR16","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.4103\/1673-5374.219031","volume":"12","author":"A Aufschnaiter","year":"2017","unstructured":"Aufschnaiter A, Kohler V, B\u00fcttner S (2017) Taking out the garbage: cathepsin D and calcineurin in neurodegeneration. Neural Regen Res 12:1776\u20131779. https:\/\/doi.org\/10.4103\/1673-5374.219031","journal-title":"Neural Regen Res"},{"key":"9989_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","volume":"256","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Fr\u00f6lich M, Schr\u00f6der-van der Elst JP, van der Bent C, Roelfsema F, Roos RAC (2009) Delayed onset of the diurnal melatonin rise in patients with Huntington\u2019s disease. J Neurol 256:1961\u20131965. https:\/\/doi.org\/10.1007\/s00415-009-5196-1","journal-title":"J Neurol"},{"key":"9989_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/nmt-2016-0008","volume":"6","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Quarrell OW (2016) The global prevalence of Huntington\u2019s disease: a systematic review and discussion. Neurodegener Dis Manag 6:331\u2013343. https:\/\/doi.org\/10.2217\/nmt-2016-0008","journal-title":"Neurodegener Dis Manag"},{"key":"9989_CR19","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005. https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Nat Rev Dis Primers"},{"key":"9989_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","volume":"1366","author":"MF Beal","year":"1998","unstructured":"Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211\u2013223","journal-title":"Biochim Biophys Acta"},{"key":"9989_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495\u2013505. https:\/\/doi.org\/10.1002\/ana.20624","journal-title":"Ann Neurol"},{"key":"9989_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","volume":"40","author":"MF Beal","year":"2011","unstructured":"Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40:1305\u20131313. https:\/\/doi.org\/10.1007\/s00726-011-0851-0","journal-title":"Amino Acids"},{"key":"9989_CR23","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"9989_CR24","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB (2002) Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation. Brain 125:1908\u20131922. https:\/\/doi.org\/10.1093\/brain\/awf180","journal-title":"Brain"},{"key":"9989_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00415-005-0595-4","volume":"252","author":"A Bender","year":"2005","unstructured":"Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T (2005) Creatine supplementation lowers brain glutamate levels in Huntington\u2019s disease. J Neurol 252:36\u201341. https:\/\/doi.org\/10.1007\/s00415-005-0595-4","journal-title":"J Neurol"},{"key":"9989_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","volume":"34","author":"M Berk","year":"2013","unstructured":"Berk M, Malhi GS, Gray LJ, Dean OM (2013) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34:167\u2013177. https:\/\/doi.org\/10.1016\/j.tips.2013.01.001","journal-title":"Trends Pharmacol Sci"},{"key":"9989_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000253483","volume":"28","author":"C Berr","year":"2009","unstructured":"Berr C, Portet F, Carriere I, Akbaraly TN, Feart C, Gourlet V, Combe N, Barberger-Gateau P, Ritchie K (2009) Olive oil and cognition: results from the three-city study. Dement Geriatr Cogn Disord 28:357\u2013364. https:\/\/doi.org\/10.1159\/000253483","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9989_CR28","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, Nairn AC, Messer A, Greengard P (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc Natl Acad Sci U S A 97:6809\u20136814. https:\/\/doi.org\/10.1073\/pnas.120166397","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR29","doi-asserted-by":"crossref","unstructured":"Bizat N, Hermel JM, Boyer F, Jacquard C, Cr\u00e9minon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E (2003) Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington\u2019s disease. J Neurosci 23:5020\u20135030","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003"},{"key":"9989_CR30","first-page":"117","volume":"41","author":"E Bonilla","year":"2000","unstructured":"Bonilla E (2000) Huntington disease. A review. Invest Clin 41:117\u2013141","journal-title":"Invest Clin"},{"key":"9989_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","volume":"697","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington\u2019s disease. Brain Res 697:254\u2013257","journal-title":"Brain Res"},{"key":"9989_CR32","doi-asserted-by":"publisher","unstructured":"Bortolatto CF, Jesse CR, Wilhelm EA, Chagas PM, Nogueira CW (2013) Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats. Neurotox Res 23:214\u2013224. https:\/\/doi.org\/10.1007\/s12640-012-9336-5","DOI":"10.1007\/s12640-012-9336-5"},{"key":"9989_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276\u2013284. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.07.021","journal-title":"Brain Res Bull"},{"key":"9989_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992) Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol 18:539\u2013547. https:\/\/doi.org\/10.1111\/j.1365-2990.1992.tb00824.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9989_CR35","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan","year":"1985","unstructured":"Brennan WA, Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J Neurochem 44:1948\u20131950","journal-title":"J Neurochem"},{"key":"9989_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0076-6879(06)12016-9","volume":"412","author":"HR Brignull","year":"2006","unstructured":"Brignull HR, Morley JF, Garcia SM, Morimoto RI (2006) Modeling polyglutamine pathogenesis in C. elegans. Meth Enzymol 412:256\u2013282. https:\/\/doi.org\/10.1016\/S0076-6879(06)12016-9","journal-title":"Meth Enzymol"},{"key":"9989_CR37","doi-asserted-by":"crossref","unstructured":"Brocardo SP, Gil-Mohapel MJ (2012) Therapeutic strategies for Huntington\u2019s disease: from the bench to the clinic. Current Psychopharmacology 1:137\u2013154","DOI":"10.2174\/2211556011201020137"},{"issue":"2","key":"9989_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/rej.2015.1736","volume":"19","author":"PS Brocardo","year":"2016","unstructured":"Brocardo PS, McGinnis E, Christie BR, Gil-Mohapel J (2016) Time-course analysis of protein and lipid oxidation in the brains of Yac128 Huntington\u2019s disease transgenic mice. Rejuvenation Res 19(2):140\u2013148. https:\/\/doi.org\/10.1089\/rej.2015.1736","journal-title":"Rejuvenation Res"},{"key":"9989_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","volume":"60","author":"E Brouillet","year":"1993","unstructured":"Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60:356\u2013359","journal-title":"J Neurochem"},{"key":"9989_CR40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E, Guyot MC, Mittoux V, Altairac S, Cond\u00e9 F, Palfi S, Hantraye P (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794\u2013805","journal-title":"J Neurochem"},{"key":"9989_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","volume":"29","author":"SE Browne","year":"2004","unstructured":"Browne SE, Beal MF (2004) The energetics of Huntington\u2019s disease. Neurochem Res 29:531\u2013546","journal-title":"Neurochem Res"},{"key":"9989_CR42","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8:2061\u20132073. https:\/\/doi.org\/10.1089\/ars.2006.8.2061","journal-title":"Antioxid Redox Signal"},{"key":"9989_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"SE Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington\u2019s disease. Brain Pathol 9:147\u2013163","journal-title":"Brain Pathol"},{"key":"9989_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0306-4522(98)00129-8","volume":"87","author":"NJ Butterworth","year":"1998","unstructured":"Butterworth NJ, Williams L, Bullock JY, Love DR, Faull RL, Dragunow M (1998) Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington\u2019s disease striatum. Neuroscience 87:49\u201353","journal-title":"Neuroscience"},{"key":"9989_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1073\/pnas.0408487101","volume":"102","author":"MJ Calkins","year":"2005","unstructured":"Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A 102:244\u2013249. https:\/\/doi.org\/10.1073\/pnas.0408487101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","volume":"1049","author":"C Carmo","year":"2018","unstructured":"Carmo C, Naia L, Lopes C, Rego AC (2018) Mitochondrial dysfunction in Huntington\u2019s disease. Adv Exp Med Biol 1049:59\u201383. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_3","journal-title":"Adv Exp Med Biol"},{"key":"9989_CR47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1046\/j.1471-4159.2001.00461.x","volume":"78","author":"M Castro","year":"2001","unstructured":"Castro M, Caprile T, Astuya A, Mill\u00e1n C, Reinicke K, Vera JC, V\u00e1squez O, Aguayo LG, Nualart F (2001) High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem 78:815\u2013823","journal-title":"J Neurochem"},{"key":"9989_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.2007.04631.x","volume":"102","author":"MA Castro","year":"2007","unstructured":"Castro MA, Pozo M, Cort\u00e9s C, Garc\u00eda MLA, Concha II, Nualart F (2007) Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. J Neurochem 102:773\u2013782. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04631.x","journal-title":"J Neurochem"},{"key":"9989_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00424-008-0526-1","volume":"457","author":"MA Castro","year":"2008","unstructured":"Castro MA, Angulo C, Brauchi S, Nualart F, Concha II (2008) Ascorbic acid participates in a general mechanism for concerted glucose transport inhibition and lactate transport stimulation. Pflugers Arch 457:519\u2013528. https:\/\/doi.org\/10.1007\/s00424-008-0526-1","journal-title":"Pflugers Arch"},{"key":"9989_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1471-4159.2009.06151.x","volume":"110","author":"MA Castro","year":"2009","unstructured":"Castro MA, Beltr\u00e1n FA, Brauchi S, Concha II (2009) A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J Neurochem 110:423\u2013440. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06151.x","journal-title":"J Neurochem"},{"key":"9989_CR51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24:182\u2013188","journal-title":"Trends Neurosci"},{"key":"9989_CR52","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1073\/pnas.0610628104","volume":"104","author":"JP Caviston","year":"2007","unstructured":"Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur ELF (2007) Huntingtin facilitates dynein\/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A 104:10045\u201310050. https:\/\/doi.org\/10.1073\/pnas.0610628104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR53","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","volume":"23","author":"C Cepeda","year":"2003","unstructured":"Cepeda C, Hurst RS, Calvert CR, Hern\u00e1ndez-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease. J Neurosci 23:961\u2013969","journal-title":"J Neurosci"},{"key":"9989_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","volume":"211","author":"C Cepeda","year":"2014","unstructured":"Cepeda C, Murphy KPS, Parent M, Levine MS (2014) The role of dopamine in Huntington\u2019s disease. Prog Brain Res 211:235\u2013254. https:\/\/doi.org\/10.1016\/B978-0-444-63425-2.00010-6","journal-title":"Prog Brain Res"},{"key":"9989_CR55","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998a) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A 95:6480\u20136485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR56","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998b) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A 95:6480\u20136485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR57","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1098\/rstb.1999.0449","volume":"354","author":"JH Cha","year":"1999","unstructured":"Cha JH, Frey AS, Alsdorf SA, Kerner JA, Kosinski CM, Mangiarini L, Penney JB, Davies SW, Bates GP, Young AB (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philos Trans R Soc Lond Ser B Biol Sci 354:981\u2013989","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"9989_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05629.x","volume":"1201","author":"CR Chang","year":"2010","unstructured":"Chang CR, Blackstone C (2010) Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci 1201:34\u201339. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05629.x","journal-title":"Ann N Y Acad Sci"},{"key":"9989_CR59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DTW Chang","year":"2006","unstructured":"Chang DTW, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22:388\u2013400. https:\/\/doi.org\/10.1016\/j.nbd.2005.12.007","journal-title":"Neurobiol Dis"},{"key":"9989_CR60","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2567.2000.00045.x","volume":"100","author":"S Chen","year":"2000","unstructured":"Chen S, Gong J, Liu F, Mohammed U (2000) Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 100:471\u2013480","journal-title":"Immunology"},{"key":"9989_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DTY (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun 359:335\u2013340. https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.093","journal-title":"Biochem Biophys Res Commun"},{"key":"9989_CR62","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","volume":"36","author":"IH Cho","year":"2012","unstructured":"Cho IH (2012) Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 36:342\u2013353. https:\/\/doi.org\/10.5142\/jgr.2012.36.4.342","journal-title":"J Ginseng Res"},{"key":"9989_CR63","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GVW, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13:1407\u20131420. https:\/\/doi.org\/10.1093\/hmg\/ddh162","journal-title":"Hum Mol Genet"},{"key":"9989_CR64","doi-asserted-by":"publisher","first-page":"67658","DOI":"10.1371\/journal.pone.0067658","volume":"8","author":"D Colle","year":"2013","unstructured":"Colle D, Santos DB, Moreira ELG, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M (2013) Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PLoS One 8:67658. https:\/\/doi.org\/10.1371\/journal.pone.0067658","journal-title":"PLoS One"},{"issue":"5","key":"9989_CR65","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","volume":"20","author":"Consortium HD, iPSC","year":"2017","unstructured":"Consortium HD, iPSC (2017) Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci 20(5):648\u2013660. https:\/\/doi.org\/10.1038\/nn.4532","journal-title":"Nat Neurosci"},{"key":"9989_CR66","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJA, Carafoli E, Scorrano L (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2:490\u2013503. https:\/\/doi.org\/10.1002\/emmm.201000102","journal-title":"EMBO Mol Med"},{"key":"9989_CR67","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1476-5381.1984.tb16227.x","volume":"83","author":"B Costall","year":"1984","unstructured":"Costall B, Kelly ME, Naylor RJ (1984) The antidyskinetic action of dihomo-\u03b3-linolenic acid in the rodent. Br J Pharmacol 83:733\u2013740. https:\/\/doi.org\/10.1111\/j.1476-5381.1984.tb16227.x","journal-title":"Br J Pharmacol"},{"key":"9989_CR68","doi-asserted-by":"publisher","unstructured":"Covarrubias-Pinto A, Moll P, Sol\u00eds-Maldonado M, Acu\u00f1a AI, Riveros A, Mir\u00f3 MP, Papic E, Beltr\u00e1n FA, Cepeda C, Concha II, Brauchi S, Castro MA (2015) Beyond the redox imbalance: oxidative stress contributes to an impaired GLUT3 modulation in Huntington\u2019s disease. Free Radic Biol Med 89:1085\u20131096. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.09.024","DOI":"10.1016\/j.freeradbiomed.2015.09.024"},{"key":"9989_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7326\/0003-4819-145-5-200609050-00006","volume":"145","author":"MI Covas","year":"2006","unstructured":"Covas MI, Nyyss\u00f6nen K, Poulsen HE, Kaikkonen J, HJF Z, Kiesewetter H, Gaddi A, de la Torre R, Mursu J, B\u00e4umler H, Nascetti S, Salonen JT, Fit\u00f3 M, Virtanen J, Marrugat J, EUROLIVE Study Group (2006) The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 145:333\u2013341","journal-title":"Ann Intern Med"},{"key":"9989_CR70","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689\u2013695","journal-title":"Science"},{"issue":"5574","key":"9989_CR71","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/263244a0","volume":"263","author":"JT Coyle","year":"1976","unstructured":"Coyle JT, Schwarcz R (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263(5574):244\u2013246","journal-title":"Nature"},{"key":"9989_CR72","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0024-3205(97)01164-8","volume":"62","author":"T Cruz","year":"1998","unstructured":"Cruz T, G\u00e1lvez J, Ocete MA, Crespo ME, S\u00e1nchez de Medina LHF, Zarzuelo A (1998) Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 62:687\u2013695","journal-title":"Life Sci"},{"key":"9989_CR73","doi-asserted-by":"publisher","unstructured":"Damiano M, Galvan L, D\u00e9glon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802:52\u201361. https:\/\/doi.org\/10.1016\/j.bbadis.2009.07.012","DOI":"10.1016\/j.bbadis.2009.07.012"},{"key":"9989_CR74","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"9989_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"O Dean","year":"2011","unstructured":"Dean O, Giorlando F, Berk M (2011) N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36:78\u201386. https:\/\/doi.org\/10.1503\/jpn.100057","journal-title":"J Psychiatry Neurosci"},{"key":"9989_CR76","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archneur.57.9.1265","volume":"57","author":"N Delanty","year":"2000","unstructured":"Delanty N, Dichter MA (2000) Antioxidant therapy in neurologic disease. Arch Neurol 57:1265\u20131270. https:\/\/doi.org\/10.1001\/archneur.57.9.1265","journal-title":"Arch Neurol"},{"key":"9989_CR77","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11745-003-1169-7","volume":"38","author":"RJ D\u00edaz","year":"2003","unstructured":"D\u00edaz RJ, Yago MD, Mart\u00ednez-Victoria E, Naranjo JA, Mart\u00ednez MA, Ma\u00f1as M (2003) Comparison of the effects of dietary sunflower oil and virgin olive oil on rat exocrine pancreatic secretion in vivo. Lipids 38:1119\u20131126","journal-title":"Lipids"},{"key":"9989_CR78","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"9989_CR79","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1126\/science.1124514","volume":"311","author":"T DiFiglia","year":"2006","unstructured":"DiFiglia T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311:1471\u20131474. https:\/\/doi.org\/10.1126\/science.1124514","journal-title":"Science"},{"key":"9989_CR80","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1073\/pnas.0500815102","volume":"102","author":"AT Dinkova-Kostova","year":"2005","unstructured":"Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, Sporn MB, Talalay P (2005) Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A 102:4584\u20134589. https:\/\/doi.org\/10.1073\/pnas.0500815102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR81","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","volume":"33","author":"NA DiProspero","year":"2004","unstructured":"DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA (2004) Early changes in Huntington\u2019s disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33:517\u2013533. https:\/\/doi.org\/10.1007\/s11068-004-0514-8","journal-title":"J Neurocytol"},{"key":"9989_CR82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","volume":"163","author":"MJ Dowie","year":"2009","unstructured":"Dowie MJ, Bradshaw HB, Howard ML, Nicholson LFB, Faull RLM, Hannan AJ, Glass M (2009) Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington\u2019s disease. Neuroscience 163:456\u2013465. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.06.014","journal-title":"Neuroscience"},{"key":"9989_CR83","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00019052-199808000-00012","volume":"11","author":"A Feigin","year":"1998","unstructured":"Feigin A (1998) Advances in Huntington\u2019s disease: implications for experimental therapeutics. Curr Opin Neurol 11:357\u2013362","journal-title":"Curr Opin Neurol"},{"key":"9989_CR84","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/mds.870110317","volume":"11","author":"A Feigin","year":"1996","unstructured":"Feigin A, Kieburtz K, Como P, Hickey C, Claude K, Abwender D, Zimmerman C, Steinberg K, Shoulson I (1996) Assessment of coenzyme Q10 tolerability in Huntington\u2019s disease. Mov Disord 11:321\u2013323. https:\/\/doi.org\/10.1002\/mds.870110317","journal-title":"Mov Disord"},{"key":"9989_CR85","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.004","volume":"539","author":"SP Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GAR, Paladini AC, Marder M (2006) Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539:168\u2013176. https:\/\/doi.org\/10.1016\/j.ejphar.2006.04.004","journal-title":"Eur J Pharmacol"},{"key":"9989_CR86","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante RJ (2009) Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim Biophys Acta 1792:506\u2013520. https:\/\/doi.org\/10.1016\/j.bbadis.2009.04.001","journal-title":"Biochim Biophys Acta"},{"key":"9989_CR87","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.2931802","volume":"230","author":"RJ Ferrante","year":"1985","unstructured":"Ferrante RJ, Kowall NW, Beal MF, Richardson EP, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington\u2019s disease. Science 230:561\u2013563","journal-title":"Science"},{"issue":"12","key":"9989_CR88","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","volume":"20","author":"RJ Ferrante","year":"2000","unstructured":"Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 20(12):4389\u20134397","journal-title":"J Neurosci"},{"key":"9989_CR89","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22:1592\u20131599","journal-title":"J Neurosci"},{"key":"9989_CR90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1359-0278(98)00002-9","volume":"3","author":"AL Fink","year":"1998","unstructured":"Fink AL (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3:9\u201323. https:\/\/doi.org\/10.1016\/S1359-0278(98)00002-9","journal-title":"Fold Des"},{"key":"9989_CR91","first-page":"375","volume":"43","author":"M Fit\u00f3","year":"2007","unstructured":"Fit\u00f3 M, de la Torre R, Farr\u00e9-Albaladejo M, Khymenetz O, Marrugat J, Covas MI (2007) Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: a review. Ann Ist Super Sanita 43:375\u2013381","journal-title":"Ann Ist Super Sanita"},{"key":"9989_CR92","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1046\/j.1471-4159.2000.0751709.x","volume":"75","author":"MA Fontaine","year":"2000","unstructured":"Fontaine MA, Geddes JW, Banks A, Butterfield DA (2000) Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington\u2019s disease. J Neurochem 75:1709\u20131715","journal-title":"J Neurochem"},{"key":"9989_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/CPAA.S35078","volume":"6","author":"B Gao","year":"2014","unstructured":"Gao B, Doan A, Hybertson BM (2014) The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clin Pharmacol 6:19\u201334. https:\/\/doi.org\/10.2147\/CPAA.S35078","journal-title":"Clin Pharmacol"},{"key":"9989_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138. https:\/\/doi.org\/10.1016\/j.cell.2004.06.018","journal-title":"Cell"},{"key":"9989_CR95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncb735","volume":"4","author":"FG Gervais","year":"2002","unstructured":"Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper DM, Roy S, Hayden MR, Nicholson DW (2002) Recruitment and activation of caspase-8 by the huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 4:95\u2013105. https:\/\/doi.org\/10.1038\/ncb735","journal-title":"Nat Cell Biol"},{"key":"9989_CR96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.mp.4001579","volume":"10","author":"E Geuze","year":"2005","unstructured":"Geuze E, Vermetten E, Bremner JD (2005) MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 10:160\u2013184. https:\/\/doi.org\/10.1038\/sj.mp.4001579","journal-title":"Mol Psychiatry"},{"key":"9989_CR97","first-page":"162","volume":"547","author":"B Ghasemzadeh","year":"1991","unstructured":"Ghasemzadeh B, Cammack J, Adams RN, Ghasemzedah B (1991) Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res 547:162\u2013166","journal-title":"Brain Res"},{"key":"9989_CR98","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27:2803\u20132820. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06310.x","journal-title":"Eur J Neurosci"},{"key":"9989_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2202-5-17","volume":"5","author":"JM Gil","year":"2004","unstructured":"Gil JM, Leist M, Popovic N, Brundin P, Peters\u00e9n \u00c5 (2004) Asialoerythropoetin is not effective in the R6\/2 line of Huntington\u2019s disease mice. BMC Neurosci 5:17. https:\/\/doi.org\/10.1186\/1471-2202-5-17","journal-title":"BMC Neurosci"},{"key":"9989_CR100","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1389450115666140115113734","volume":"15","author":"J Gil-Mohapel","year":"2014","unstructured":"Gil-Mohapel J, Brocardo PS, Christie BR (2014) The role of oxidative stress in Huntington\u2019s disease: are antioxidants good therapeutic candidates? Curr Drug Targets 15:454\u2013468","journal-title":"Curr Drug Targets"},{"issue":"2","key":"9989_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JHD-120023s","volume":"1","author":"A Giralt","year":"2012","unstructured":"Giralt A, Saavedra A, Alberch J, P\u00e9rez-Navarro E (2012) Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis 1(2):155\u2013173. https:\/\/doi.org\/10.3233\/JHD-120023s","journal-title":"J Huntingtons Dis"},{"key":"9989_CR102","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2008.09.022","volume":"446","author":"JA Gonz\u00e1lez-Correa","year":"2008","unstructured":"Gonz\u00e1lez-Correa JA, Navas MD, Lopez-Villodres JA, Trujillo M, Espartero JL, De La Cruz JP (2008) Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci Lett 446:143\u2013146. https:\/\/doi.org\/10.1016\/j.neulet.2008.09.022","journal-title":"Neurosci Lett"},{"key":"9989_CR103","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andr\u00e9 VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195. https:\/\/doi.org\/10.1523\/JNEUROSCI.0857-08.2008","journal-title":"J Neurosci"},{"issue":"8","key":"9989_CR104","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","volume":"22","author":"HE Grote","year":"2005","unstructured":"Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Bartlett PF, Hannan AJ (2005) Cognitive disorders and neurogenesis deficits in Huntington\u2019s disease mice are rescued by fluoxetine. Eur J Neurosci 22(8):2081\u20132088","journal-title":"Eur J Neurosci"},{"key":"9989_CR105","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389. https:\/\/doi.org\/10.1002\/ana.410390317","journal-title":"Ann Neurol"},{"key":"9989_CR106","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","volume":"40","author":"S Gunawardena","year":"2003","unstructured":"Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LSB (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25\u201340","journal-title":"Neuron"},{"key":"9989_CR107","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8:2003\u20132014. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"key":"9989_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/318075a0","volume":"318","author":"JF Gusella","year":"1985","unstructured":"Gusella JF, Tanzi RE, Bader PI, Phelan MC, Stevenson R, Hayden MR, Hofman KJ, Faryniarz AG, Gibbons K (1985) Deletion of Huntington\u2019s disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature 318:75\u201378","journal-title":"Nature"},{"key":"9989_CR109","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","volume":"79","author":"MC Guyot","year":"1997","unstructured":"Guyot MC, Hantraye P, Dolan R, Palfi S, Mazi\u00e9re M, Brouillet E (1997) Quantifiable bradykinesia, gait abnormalities and Huntington\u2019s disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79:45\u201356","journal-title":"Neuroscience"},{"key":"9989_CR110","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1096\/fasebj.13.2.411","volume":"13","author":"TM Hagen","year":"1999","unstructured":"Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames AB (1999) (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 13:411\u2013418","journal-title":"FASEB J"},{"key":"9989_CR111","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s004010050408","volume":"91","author":"H Heinsen","year":"1996","unstructured":"Heinsen H, R\u00fcb U, Gangnus D, Jungkunz G, Bauer M, Ulmar G, Bethke B, Sch\u00fcler M, B\u00f6cker F, Eisenmenger W, G\u00f6tz M, Strik M (1996) Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington\u2019s disease. Acta Neuropathol 91:161\u2013168","journal-title":"Acta Neuropathol"},{"key":"9989_CR112","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2193-1801-2-56","volume":"2","author":"Y Henrotin","year":"2013","unstructured":"Henrotin Y, Priem F, Mobasheri A (2013) Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus 2:56. https:\/\/doi.org\/10.1186\/2193-1801-2-56","journal-title":"Springerplus"},{"key":"9989_CR113","doi-asserted-by":"publisher","first-page":"13662","DOI":"10.1523\/JNEUROSCI.4144-08.2008","volume":"28","author":"LS Her","year":"2008","unstructured":"Her LS, Goldstein LSB (2008) Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J Neurosci 28:13662\u201313672. https:\/\/doi.org\/10.1523\/JNEUROSCI.4144-08.2008","journal-title":"J Neurosci"},{"key":"9989_CR114","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","volume":"1","author":"SM Hersch","year":"2004","unstructured":"Hersch SM, Ferrante RJ (2004) Translating therapies for Huntington\u2019s disease from genetic animal models to clinical trials. NeuroRx 1:298\u2013306","journal-title":"NeuroRx"},{"key":"9989_CR115","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","volume":"66","author":"SM Hersch","year":"2006","unstructured":"Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, Zaleta A, Kaneko Y, Jenkins B, Hevelone N, Zhang H, Yu H, Schoenfeld D, Ferrante R, Rosas HD (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG. Neurology 66:250\u2013252. https:\/\/doi.org\/10.1212\/01.wnl.0000194318.74946.b6","journal-title":"Neurology"},{"key":"9989_CR116","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1212\/WNL.0000000000004209","volume":"89","author":"SM Hersch","year":"2017","unstructured":"Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD (2017) The CREST-E study of creatine for Huntington disease. Neurology 89:594\u2013601. https:\/\/doi.org\/10.1212\/WNL.0000000000004209","journal-title":"Neurology"},{"issue":"1","key":"9989_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S0033291799002871","volume":"31","author":"LW Ho","year":"2001","unstructured":"Ho LW, Carmichael J, Swartz J, Wyttenbach A, Rankin J, Rubinsztein DC (2001) The molecular biology of Huntington's disease. Psychol Med 31(1):3\u201314","journal-title":"Psychol Med"},{"key":"9989_CR118","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/hmg\/5.12.1875","volume":"5","author":"JG Hodgson","year":"1996","unstructured":"Hodgson JG, Smith DJ, McCutcheon K, Koide HB, Nishiyama K, Dinulos MB, Stevens ME, Bissada N, Nasir J, Kanazawa I, Disteche CM, Rubin EM, Hayden MR (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum Mol Genet 5:1875\u20131885","journal-title":"Hum Mol Genet"},{"key":"9989_CR119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"9989_CR120","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0960-894X(02)00105-1","volume":"12","author":"T Honda","year":"2002","unstructured":"Honda T, Honda Y, Favaloro FG, Gribble GW, Suh N, Place AE, Rendi MH, Sporn MB (2002) A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production. Bioorg Med Chem Lett 12:1027\u20131030","journal-title":"Bioorg Med Chem Lett"},{"key":"9989_CR121","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tox.2008.11.005","volume":"256","author":"F Huang","year":"2009","unstructured":"Huang F, Ning H, Xin QQ, Huang Y, Wang H, Zhang ZH, Xu DX, Ichihara G, Ye DQ (2009) Melatonin pretreatment attenuates 2-bromopropane-induced testicular toxicity in rats. Toxicology 256:75\u201382. https:\/\/doi.org\/10.1016\/j.tox.2008.11.005","journal-title":"Toxicology"},{"key":"9989_CR122","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","volume":"57","author":"Huntington Study Group","year":"2001","unstructured":"Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57:397\u2013404","journal-title":"Neurology"},{"key":"9989_CR123","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/mds.22408","volume":"25","author":"HC Hyson","year":"2010","unstructured":"Huntington Study Group Pre2CARE Investigators, Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Cudkowicz ME, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, Metakis LJ (2010) Safety and tolerability of high-dosage coenzyme Q10 in Huntington\u2019s disease and healthy subjects. Mov Disord 25:1924\u20131928. https:\/\/doi.org\/10.1002\/mds.22408","journal-title":"Mov Disord"},{"key":"9989_CR124","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1046\/j.1471-4159.2000.0750830.x","volume":"75","author":"C Iannicola","year":"2000","unstructured":"Iannicola C, Moreno S, Oliverio S, Nardacci R, Ciofi-Luzzatto A, Piacentini M (2000) Early alterations in gene expression and cell morphology in a mouse model of Huntington\u2019s disease. J Neurochem 75:830\u2013839. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0750830.x","journal-title":"J Neurochem"},{"key":"9989_CR125","first-page":"129","volume":"1","author":"CC Irwin","year":"1989","unstructured":"Irwin CC, Wexler NS, Young AB, Ozelius LJ, Penney JB, Shoulson I, Snodgrass SR, Ramos-Arroyo MA, Sanchez-Ramos J, Penchaszadeh GK (1989) The role of mitochondrial DNA in Huntington\u2019s disease. J Mol Neurosci 1:129\u2013136","journal-title":"J Mol Neurosci"},{"key":"9989_CR126","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","volume":"21","author":"GR Jackson","year":"1998","unstructured":"Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW, MacDonald ME, Zipursky SL (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21:633\u2013642","journal-title":"Neuron"},{"key":"9989_CR127","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5455\/jice.20140903012921","volume":"3","author":"D Jain","year":"2014","unstructured":"Jain D, Gangshettiwar A (2014) Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington\u2019s disease in rats. J Intercult Ethnopharmacol 3:186\u2013191. https:\/\/doi.org\/10.5455\/jice.20140903012921","journal-title":"J Intercult Ethnopharmacol"},{"key":"9989_CR128","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12640-017-9766-1","volume":"32","author":"M Jodeiri Farshbaf","year":"2017","unstructured":"Jodeiri Farshbaf M, Ghaedi K (2017) Huntington\u2019s disease and mitochondria. Neurotox Res 32:518\u2013529. https:\/\/doi.org\/10.1007\/s12640-017-9766-1","journal-title":"Neurotox Res"},{"key":"9989_CR129","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","volume":"97","author":"MA Johnson","year":"2006","unstructured":"Johnson MA, Rajan V, Miller CE, Wightman RM (2006) Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease. J Neurochem 97:737\u2013746. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03762.x","journal-title":"J Neurochem"},{"key":"9989_CR130","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/j.1471-4159.2007.04908.x","volume":"103","author":"MA Johnson","year":"2007","unstructured":"Johnson MA, Villanueva M, Haynes CL, Seipel AT, Buhler LA, Wightman RM (2007) Catecholamine exocytosis is diminished in R6\/2 Huntington\u2019s disease model mice. J Neurochem 103:2102\u20132110. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04908.x","journal-title":"J Neurochem"},{"key":"9989_CR131","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342:619\u2013630. https:\/\/doi.org\/10.1124\/jpet.112.192138","journal-title":"J Pharmacol Exp Ther"},{"key":"9989_CR132","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nm0311-245","volume":"17","author":"A Johri","year":"2011","unstructured":"Johri A, Chaturvedi RK, Beal MF (2011) Hugging tight in Huntington\u2019s. Nat Med 17:245\u2013246. https:\/\/doi.org\/10.1038\/nm0311-245","journal-title":"Nat Med"},{"key":"9989_CR133","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","volume":"29","author":"PR Joshi","year":"2009","unstructured":"Joshi PR, Wu NP, Andr\u00e9 VM, Cummings DM, Cepeda C, Joyce JA, Carroll JB, Leavitt BR, Hayden MR, Levine MS, Bamford NS (2009) Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 29:2414\u20132427. https:\/\/doi.org\/10.1523\/JNEUROSCI.5687-08.2009","journal-title":"J Neurosci"},{"key":"9989_CR134","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/cercor\/bhh185","volume":"15","author":"J Kassubek","year":"2005","unstructured":"Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB (2005) Thalamic atrophy in Huntington\u2019s disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 15:846\u2013853. https:\/\/doi.org\/10.1093\/cercor\/bhh185","journal-title":"Cereb Cortex"},{"key":"9989_CR135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.foodchem.2005.03.019","volume":"97","author":"T Katsube","year":"2006","unstructured":"Katsube T, Imawaka N, Kawano Y, Yamazaki Y, Shiwaku K, Yamane Y (2006) Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 97:25\u201331. https:\/\/doi.org\/10.1016\/j.foodchem.2005.03.019","journal-title":"Food Chem"},{"key":"9989_CR136","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.870110310","volume":"11","author":"K Kieburtz","year":"1996","unstructured":"Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, Hickey C, Orme C, Claude K, Sotack J, Greenamyre JT, Dunn C, Shoulson I (1996) A controlled trial of remacemide hydrochloride in Huntington\u2019s disease. Mov Disord 11:273\u2013277. https:\/\/doi.org\/10.1002\/mds.870110310","journal-title":"Mov Disord"},{"key":"9989_CR137","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.biortech.2004.12.025","volume":"96","author":"KH Kim","year":"2005","unstructured":"Kim KH, Lee KW, Kim DY, Park HH, Kwon IB, Lee HJ (2005) Optimal recovery of high-purity rutin crystals from the whole plant of Fagopyrum esculentum Moench (buckwheat) by extraction, fractionation, and recrystallization. Bioresour Technol 96:1709\u20131712. https:\/\/doi.org\/10.1016\/j.biortech.2004.12.025","journal-title":"Bioresour Technol"},{"key":"9989_CR138","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19:3919\u20133935. https:\/\/doi.org\/10.1093\/hmg\/ddq306","journal-title":"Hum Mol Genet"},{"key":"9989_CR139","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","volume":"86","author":"GJ Klapstein","year":"2001","unstructured":"Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice. J Neurophysiol 86:2667\u20132677. https:\/\/doi.org\/10.1152\/jn.2001.86.6.2667","journal-title":"J Neurophysiol"},{"issue":"7","key":"9989_CR140","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/nu9070659","volume":"9","author":"J Kocot","year":"2017","unstructured":"Kocot J, Luchowska-Kocot D, Kie\u0142czykowska M, Musik I, Kurzepa J (2017) Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients 9(7):659. https:\/\/doi.org\/10.3390\/nu9070659","journal-title":"Nutrients"},{"key":"9989_CR141","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.nutres.2008.06.004","volume":"28","author":"T Koda","year":"2008","unstructured":"Koda T, Kuroda Y, Imai H (2008) Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats. Nutr Res 28:629\u2013634. https:\/\/doi.org\/10.1016\/j.nutres.2008.06.004","journal-title":"Nutr Res"},{"key":"9989_CR142","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2174\/092986705774370646","volume":"12","author":"P Kovacic","year":"2005","unstructured":"Kovacic P, Pozos RS, Somanathan R, Shangari N, O\u2019Brien PJ (2005) Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. Curr Med Chem 12:2601\u20132623. https:\/\/doi.org\/10.2174\/092986705774370646","journal-title":"Curr Med Chem"},{"key":"9989_CR143","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","volume":"49","author":"HP Kremer","year":"1990","unstructured":"Kremer HP, Roos RA, Dingjan G, Marani E, Bots GT (1990) Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease. J Neuropathol Exp Neurol 49:371\u2013382","journal-title":"J Neuropathol Exp Neurol"},{"key":"9989_CR144","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1016\/j.fct.2009.07.011","volume":"47","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 47:2522\u20132530. https:\/\/doi.org\/10.1016\/j.fct.2009.07.011","journal-title":"Food Chem Toxicol"},{"key":"9989_CR145","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbr.2009.08.028","volume":"206","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington\u2019s like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38\u201346. https:\/\/doi.org\/10.1016\/j.bbr.2009.08.028","journal-title":"Behav Brain Res"},{"key":"9989_CR146","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR (2016) Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly. J Huntingtons Dis 5:217\u2013237. https:\/\/doi.org\/10.3233\/JHD-160205","journal-title":"J Huntingtons Dis"},{"key":"9989_CR147","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/01480541003642050","volume":"33","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kalonia H, Kumar A (2010) Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. Drug Chem Toxicol 33:377\u2013392. https:\/\/doi.org\/10.3109\/01480541003642050","journal-title":"Drug Chem Toxicol"},{"key":"9989_CR148","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.drudis.2014.03.016","volume":"19","author":"A Kumar","year":"2014","unstructured":"Kumar A, Vaish M, Ratan RR (2014) Transcriptional dysregulation in Huntington\u2019s disease: a failure of adaptive transcriptional homeostasis. Drug Discov Today 19:956\u2013962. https:\/\/doi.org\/10.1016\/j.drudis.2014.03.016","journal-title":"Drug Discov Today"},{"key":"9989_CR149","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21:9112\u20139123","journal-title":"J Neurosci"},{"key":"9989_CR150","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","volume":"290","author":"JM Lawler","year":"2002","unstructured":"Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290:47\u201352. https:\/\/doi.org\/10.1006\/bbrc.2001.6164","journal-title":"Biochem Biophys Res Commun"},{"key":"9989_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01489.x","volume":"49","author":"E Lehrmann","year":"2008","unstructured":"Lehrmann E, Guidetti P, L\u00f6ve A, Williamson J, Bertram EH, Schwarcz R (2008) Glial activation precedes seizures and hippocampal neurodegeneration in measles virus\u2013infected mice. Epilepsia 49:13\u201323. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01489.x","journal-title":"Epilepsia"},{"key":"9989_CR152","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","volume":"21","author":"H Li","year":"2001","unstructured":"Li H, Li SH, Yu ZX, Shelbourne P, Li XJ (2001) Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington\u2019s disease mice. J Neurosci 21:8473\u20138481","journal-title":"J Neurosci"},{"key":"9989_CR153","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","volume":"12","author":"H Li","year":"2003","unstructured":"Li H, Wyman T, Yu ZX, Li SH, Li XJ (2003) Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet 12:2021\u20132030. https:\/\/doi.org\/10.1093\/hmg\/ddg218","journal-title":"Hum Mol Genet"},{"key":"9989_CR154","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-04-4539","volume":"65","author":"K Liby","year":"2005","unstructured":"Liby K, Hock T, Yore MM, Suh N, Place AE, Risingsong R, Williams CR, Royce DB, Honda T, Honda Y, Gribble GW, Hill-Kapturczak N, Agarwal A, Sporn MB (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2\/ARE signaling. Cancer Res 65:4789\u20134798. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4539","journal-title":"Cancer Res"},{"key":"9989_CR155","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Li\u00e9vens","year":"2001","unstructured":"Li\u00e9vens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L, Bates GP (2001) Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice. Neurobiol Dis 8:807\u2013821. https:\/\/doi.org\/10.1006\/nbdi.2001.0430","journal-title":"Neurobiol Dis"},{"key":"9989_CR156","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 283:5780\u20135789. https:\/\/doi.org\/10.1074\/jbc.M704704200","journal-title":"J Biol Chem"},{"key":"9989_CR157","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"key":"9989_CR158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fncir.2018.00003","volume":"12","author":"R Lindroos","year":"2018","unstructured":"Lindroos R, Dorst MC, Du K, Filipovi\u0107 M, Keller D, Ketzef M, Kozlov AK, Kumar A, Lindahl M, Nair AG, P\u00e9rez-Fern\u00e1ndez J, Grillner S, Silberberg G, Hellgren Kotaleski J (2018) Basal ganglia neuromodulation over multiple temporal and structural scales\u2014simulations of direct pathway MSNs investigate the fast onset of dopaminergic effects and predict the role of Kv4.2. Front Neural Circuits 12:3. https:\/\/doi.org\/10.3389\/fncir.2018.00003","journal-title":"Front Neural Circuits"},{"key":"9989_CR159","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archopht.1957.00940010205006","volume":"58","author":"DR Lucas","year":"1957","unstructured":"Lucas DR, Newhouse JP (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58:193\u2013201","journal-title":"AMA Arch Ophthalmol"},{"key":"9989_CR160","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492\u2013498","journal-title":"Can J Neurol Sci"},{"key":"9989_CR161","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA, Borchelt DR, Tapscott SJ, Young AB, Cha JH, Olson JM (2000a) Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 9:1259\u20131271","journal-title":"Hum Mol Genet"},{"key":"9989_CR162","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA, Borchelt DR, Tapscott SJ, Young AB, Cha JHJ, Olson JM (2000b) Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 9:1259\u20131271. https:\/\/doi.org\/10.1093\/hmg\/9.9.1259","journal-title":"Hum Mol Genet"},{"key":"9989_CR163","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00001756-199011000-00004","volume":"1","author":"MD Majewska","year":"1990","unstructured":"Majewska MD, Bell JA (1990) Ascorbic acid protects neurons from injury induced by glutamate and NMDA. Neuroreport 1:194\u2013196","journal-title":"Neuroreport"},{"key":"9989_CR164","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506. https:\/\/doi.org\/10.1016\/S0092-8674(00)81369-0","journal-title":"Cell"},{"key":"9989_CR165","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","volume":"95","author":"RT Matthews","year":"1998","unstructured":"Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A 95:8892\u20138897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR166","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/abbi.1997.0473","volume":"349","author":"JM May","year":"1998","unstructured":"May JM, Qu ZC, Mendiratta S (1998) Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 349:281\u2013289. https:\/\/doi.org\/10.1006\/abbi.1997.0473","journal-title":"Arch Biochem Biophys"},{"key":"9989_CR167","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1074\/jbc.M509806200","volume":"281","author":"JR McGuire","year":"2006","unstructured":"McGuire JR, Rong J, Li SH, Li XJ (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem 281:3552\u20133559. https:\/\/doi.org\/10.1074\/jbc.M509806200","journal-title":"J Biol Chem"},{"issue":"1","key":"9989_CR168","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00415-009-1005-0","volume":"256","author":"T Meier","year":"2009","unstructured":"Meier T, Buyse G (2009) Idebenone: an emerging therapy for Friedreich ataxia. J Neurol 256(1):25\u201330. https:\/\/doi.org\/10.1007\/s00415-009-1005-0","journal-title":"J Neurol"},{"key":"9989_CR169","doi-asserted-by":"publisher","unstructured":"Mendiratta S, Qu Z, May JM (1998) Erythrocyte defenses against hydrogen peroxide: the role of ascorbic acid. Biochimica et Biophysica Acta (BBA) 1380:389\u2013395. https:\/\/doi.org\/10.1016\/S0304-4165(98)00005-1","DOI":"10.1016\/S0304-4165(98)00005-1"},{"key":"9989_CR170","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0014-4886(90)90005-D","volume":"108","author":"M Miyamoto","year":"1990","unstructured":"Miyamoto M, Coyle JT (1990) Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp Neurol 108:38\u201345. https:\/\/doi.org\/10.1016\/0014-4886(90)90005-D","journal-title":"Exp Neurol"},{"key":"9989_CR171","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31:21\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"9989_CR172","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/1028415X.2016.1147683","volume":"20","author":"A Morales-Mart\u00ednez","year":"2017","unstructured":"Morales-Mart\u00ednez A, S\u00e1nchez-Mendoza A, Mart\u00ednez-Lazcano JC, Pineda-Far\u00edas JB, Montes S, El-Hafidi M, Mart\u00ednez-Gopar PE, Trist\u00e1n-L\u00f3pez L, P\u00e9rez-Neri I, Zamorano-Carrillo A, Castro N, R\u00edos C, P\u00e9rez-Severiano F (2017) Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats. Nutr Neurosci 20:388\u2013395. https:\/\/doi.org\/10.1080\/1028415X.2016.1147683","journal-title":"Nutr Neurosci"},{"key":"9989_CR173","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.expneurol.2012.10.014","volume":"243","author":"AJ Morton","year":"2013","unstructured":"Morton AJ (2013) Circadian and sleep disorder in Huntington\u2019s disease. Exp Neurol 243:34\u201344. https:\/\/doi.org\/10.1016\/j.expneurol.2012.10.014","journal-title":"Exp Neurol"},{"key":"9989_CR174","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JHD-130050","volume":"2","author":"AJ Morton","year":"2013","unstructured":"Morton AJ, Howland DS (2013) Large genetic animal models of Huntington\u2019s disease. J Huntington\u2019s Dis 2:3\u201319. https:\/\/doi.org\/10.3233\/JHD-130050","journal-title":"J Huntington\u2019s Dis"},{"key":"9989_CR175","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","volume":"56","author":"AJ Morton","year":"2001","unstructured":"Morton AJ, Faull RL, Edwardson JM (2001) Abnormalities in the synaptic vesicle fusion machinery in Huntington\u2019s disease. Brain Res Bull 56:111\u2013117","journal-title":"Brain Res Bull"},{"issue":"11","key":"9989_CR176","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1080\/10408398.2013.801827","volume":"56","author":"L M\u00fcller","year":"2016","unstructured":"M\u00fcller L, Caris-Veyrat C, Lowe G, B\u00f6hm V (2016) Lycopene and its antioxidant role in the prevention of cardiovascular diseases\u2014a critical review. Crit Rev Food Sci Nutr 56(11):1868\u20131879. https:\/\/doi.org\/10.1080\/10408398.2013.801827","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9989_CR177","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation. J Neurosci 20:5115\u20135123","journal-title":"J Neurosci"},{"key":"9989_CR178","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","volume":"15","author":"HP Nguyen","year":"2006","unstructured":"Nguyen HP, Kobbe P, Rahne H, W\u00f6rpel T, J\u00e4ger B, Stephan M, Pabst R, Holzmann C, Riess O, Korr H, K\u00e1ntor O, Petrasch-Parwez E, Wetzel R, Osmand A, von H\u00f6rsten S (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington\u2019s disease. Hum Mol Genet 15:3177\u20133194 https:\/\/doi.org\/10.1093\/hmg\/ddl394","journal-title":"Hum Mol Genet"},{"key":"9989_CR179","volume-title":"Clinical uses of essential fatty acids","author":"V Nohria","year":"1982","unstructured":"Nohria V, Vaddadi KS (1982) Tardive dyskinesias and essential fatty acids: an animal model study. In: Horrobin DF (ed) Clinical uses of essential fatty acids. Eden Press, Montreal"},{"key":"9989_CR180","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06501.x","volume":"112","author":"AN Ortiz","year":"2010","unstructured":"Ortiz AN, Kurth BJ, Osterhaus GL, Johnson MA (2010) Dysregulation of intracellular dopamine stores revealed in the R6\/2 mouse striatum. J Neurochem 112:755\u2013761. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06501.x","journal-title":"J Neurochem"},{"key":"9989_CR181","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","volume":"15","author":"S Palfi","year":"2007","unstructured":"Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Cond\u00e9 F, Li XJ, Aebischer P, Hantraye P, D\u00e9glon N (2007) Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 15:1444\u20131451. https:\/\/doi.org\/10.1038\/sj.mt.6300185","journal-title":"Mol Ther"},{"key":"9989_CR182","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736. https:\/\/doi.org\/10.1038\/nn884","journal-title":"Nat Neurosci"},{"key":"9989_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0003-9861(02)00585-4","volume":"410","author":"AV Panov","year":"2003","unstructured":"Panov AV, Burke JR, Strittmatter WJ, Greenamyre JT (2003) In vitro effects of polyglutamine tracts on Ca2+\u2212dependent depolarization of rat and human mitochondria: relevance to Huntington\u2019s disease. Arch Biochem Biophys 410:1\u20136","journal-title":"Arch Biochem Biophys"},{"key":"9989_CR184","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","volume":"28","author":"P Paoletti","year":"2008","unstructured":"Paoletti P, Vila I, Rif\u00e9 M, Lizcano JM, Alberch J, Gin\u00e9s S (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5. J Neurosci 28:10090\u201310101. https:\/\/doi.org\/10.1523\/JNEUROSCI.3237-08.2008","journal-title":"J Neurosci"},{"key":"9989_CR185","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry 59:57\u201363. https:\/\/doi.org\/10.1016\/j.biopsych.2005.06.003","journal-title":"Biol Psychiatry"},{"key":"9989_CR186","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0006-8993(99)02320-3","volume":"857","author":"A Peters\u00e9n","year":"2000","unstructured":"Peters\u00e9n A, Castilho RF, Hansson O, Wieloch T, Brundin P (2000) Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Res 857:20\u201329","journal-title":"Brain Res"},{"key":"9989_CR187","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/exnr.2002.7885","volume":"175","author":"A Peters\u00e9n","year":"2002","unstructured":"Peters\u00e9n A, Chase K, Puschban Z, DiFiglia M, Brundin P, Aronin N (2002) Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington\u2019s disease. Exp Neurol 175:297\u2013300. https:\/\/doi.org\/10.1006\/exnr.2002.7885","journal-title":"Exp Neurol"},{"key":"9989_CR188","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/hmg\/ddi004","volume":"14","author":"A Peters\u00e9n","year":"2005","unstructured":"Peters\u00e9n A, Gil J, Maat-Schieman MLC, Bj\u00f6rkqvist M, Tanila H, Ara\u00fajo IM, Smith R, Popovic N, Wierup N, Norl\u00e9n P, Li JY, Roos RAC, Sundler F, Mulder H, Brundin P (2005) Orexin loss in Huntington\u2019s disease. Hum Mol Genet 14:39\u201347. https:\/\/doi.org\/10.1093\/hmg\/ddi004","journal-title":"Hum Mol Genet"},{"issue":"9","key":"9989_CR189","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/cercor\/bhu065","volume":"25","author":"O Phillips","year":"2015","unstructured":"Phillips O, Squitieri F, Sanchez-Castaneda C, Elifani F, Griguoli A, Maglione V, Caltagirone C, Sabatini U, Di Paola M (2015) The corticospinal tract in Huntington\u2019s disease. Cereb Cortex 25(9):2670\u20132682. https:\/\/doi.org\/10.1093\/cercor\/bhu065","journal-title":"Cereb Cortex"},{"key":"9989_CR190","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/rej.2014.1591","volume":"17","author":"L Phom","year":"2014","unstructured":"Phom L, Achumi B, Alone DP, Muralidhara YSC (2014) Curcumin\u2019s neuroprotective efficacy in Drosophila model of idiopathic Parkinson\u2019s disease is phase specific: implication of its therapeutic effectiveness. Rejuvenation Res 17:481\u2013489. https:\/\/doi.org\/10.1089\/rej.2014.1591","journal-title":"Rejuvenation Res"},{"key":"9989_CR191","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/01.wco.0000137538.84115.3c","volume":"17","author":"P Piccini","year":"2004","unstructured":"Piccini P (2004) Neurodegenerative movement disorders: the contribution of functional imaging. Curr Opin Neurol 17:459\u2013466","journal-title":"Curr Opin Neurol"},{"key":"9989_CR192","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85:257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"9989_CR193","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","volume":"25","author":"A Polyzos","year":"2016","unstructured":"Polyzos A, Holt A, Brown C, Cosme C, Wipf P, Gomez-Marin A, Castro MR, Ayala-Pe\u00f1a S, McMurray CT (2016) Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes. Hum Mol Genet 25:1792\u20131802. https:\/\/doi.org\/10.1093\/hmg\/ddw051","journal-title":"Hum Mol Genet"},{"key":"9989_CR194","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","volume":"15","author":"C Portera-Cailliau","year":"1995","unstructured":"Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775\u20133787","journal-title":"J Neurosci"},{"key":"9989_CR195","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/hmg\/dds037","volume":"21","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, Deng Y, Butland S, Zhang W, Cheng SH, Shihabuddin LS, Hayden MR (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21:2219\u20132232. https:\/\/doi.org\/10.1093\/hmg\/dds037","journal-title":"Hum Mol Genet"},{"key":"9989_CR196","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27:1083\u20131091. https:\/\/doi.org\/10.1002\/mds.25075","journal-title":"Mov Disord"},{"key":"9989_CR197","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2006.01.007","volume":"341","author":"KL Puranam","year":"2006","unstructured":"Puranam KL, Wu G, Strittmatter WJ, Burke JR (2006) Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria. Biochem Biophys Res Commun 341:607\u2013613. https:\/\/doi.org\/10.1016\/j.bbrc.2006.01.007","journal-title":"Biochem Biophys Res Commun"},{"key":"9989_CR198","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.exger.2004.05.002","volume":"39","author":"JL Quiles","year":"2004","unstructured":"Quiles JL, Ochoa JJ, Ramirez-Tortosa C, Battino M, Huertas JR, Mart\u00edn Y, Mataix J (2004) Dietary fat type (virgin olive vs. sunflower oils) affects age-related changes in DNA double-strand-breaks, antioxidant capacity and blood lipids in rats. Exp Gerontol 39:1189\u20131198. https:\/\/doi.org\/10.1016\/j.exger.2004.05.002","journal-title":"Exp Gerontol"},{"key":"9989_CR199","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","volume":"80","author":"RA Quintanilla","year":"2009","unstructured":"Quintanilla RA, Johnson GVW (2009) Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease. Brain Res Bull 80:242\u2013247. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.07.010","journal-title":"Brain Res Bull"},{"key":"9989_CR200","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2016.05.015","volume":"23","author":"L Quinti","year":"2016","unstructured":"Quinti L, Casale M, Moniot S, Pais TF, Van Kanegan MJ, Kaltenbach LS, Pallos J, Lim RG, Naidu SD, Runne H, Meisel L, Rauf NA, Leyfer D, Maxwell MM, Saiah E, Landers JE, Luthi-Carter R, Abagyan R, Dinkova-Kostova AT, Steegborn C, Marsh JL, Lo DC, Thompson LM, Kazantsev AG (2016) SIRT2- and NRF2-targeting thiazole-containing compound with therapeutic activity in Huntington\u2019s disease models. Cell Chem Biol 23:849\u2013861. https:\/\/doi.org\/10.1016\/j.chembiol.2016.05.015","journal-title":"Cell Chem Biol"},{"key":"9989_CR201","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u2013373","journal-title":"ILAR J"},{"key":"9989_CR202","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mds.870110510","volume":"11","author":"NG Ranen","year":"1996","unstructured":"Ranen NG, Peyser CE, Coyle JT, Bylsma FW, Sherr M, Day L, Folstein MF, Brandt J, Ross CA, Folstein SE (1996) A controlled trial of idebenone in Huntington\u2019s disease. Mov Disord 11:549\u2013554. https:\/\/doi.org\/10.1002\/mds.870110510","journal-title":"Mov Disord"},{"key":"9989_CR203","doi-asserted-by":"publisher","unstructured":"Ransome MI, Renoir T, Hannan AJ (2012) Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington\u2019s disease. Neural Plasticity 7. https:\/\/doi.org\/10.1155\/2012\/874387","DOI":"10.1155\/2012\/874387"},{"key":"9989_CR204","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4161\/cc.20423","volume":"11","author":"T Ratovitski","year":"2012","unstructured":"Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN, Ross CA (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11:2006\u20132021. https:\/\/doi.org\/10.4161\/cc.20423","journal-title":"Cell Cycle"},{"key":"9989_CR205","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJW, Smeeth L (2016) The prevalence of Huntington\u2019s disease. Neuroepidemiology 46:144\u2013153. https:\/\/doi.org\/10.1159\/000443738","journal-title":"Neuroepidemiology"},{"key":"9989_CR206","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andr\u00e9 VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS (2011) Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198:252\u2013273. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.052","journal-title":"Neuroscience"},{"key":"9989_CR207","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1523\/JNEUROSCI.22-02-j0006.2002","volume":"22","author":"GV Rebec","year":"2002","unstructured":"Rebec GV, Barton SJ, Ennis MD (2002) Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington\u2019s disease gene. J Neurosci 22:202","journal-title":"J Neurosci"},{"key":"9989_CR208","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/00001756-200307010-00015","volume":"14","author":"GV Rebec","year":"2003","unstructured":"Rebec GV, Barton SJ, Marseilles AM, Collins K (2003) Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport 14:1263\u20131265. https:\/\/doi.org\/10.1097\/01.wnr.0000081868.45938.12","journal-title":"Neuroreport"},{"key":"9989_CR209","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"PH Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO, Miller G, Tagle DA (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20:198\u2013202. https:\/\/doi.org\/10.1038\/2510","journal-title":"Nat Genet"},{"key":"9989_CR210","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85:5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9989_CR211","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/mds.25624","volume":"28","author":"A Reiner","year":"2013","unstructured":"Reiner A, Shelby E, Wang H, Demarch Z, Deng Y, Guley NH, Hogg V, Roxburgh R, Tippett LJ, Waldvogel HJ, Faull RLM (2013) Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia. Mov Disord 28:1691\u20131699. https:\/\/doi.org\/10.1002\/mds.25624","journal-title":"Mov Disord"},{"key":"9989_CR212","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","volume":"30","author":"FM Ribeiro","year":"2010","unstructured":"Ribeiro FM, Paquet M, Ferreira LT, Cregan T, Swan P, Cregan SP, Ferguson SSG (2010) Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington\u2019s disease. J Neurosci 30:316\u2013324. https:\/\/doi.org\/10.1523\/JNEUROSCI.4974-09.2010","journal-title":"J Neurosci"},{"key":"9989_CR213","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.phrs.2008.05.002","volume":"57","author":"D Richard","year":"2008","unstructured":"Richard D, Kefi K, Barbe U, Bausero P, Visioli F (2008) Polyunsaturated fatty acids as antioxidants. Pharmacol Res 57:451\u2013455. https:\/\/doi.org\/10.1016\/j.phrs.2008.05.002","journal-title":"Pharmacol Res"},{"key":"9989_CR214","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A, Hayden MR, Li Y, Cooper JK, Ross CA, Govoni S, Vincenz C, Cattaneo E (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20:3705\u20133713","journal-title":"J Neurosci"},{"key":"9989_CR215","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1074\/jbc.C100044200","volume":"276","author":"D Rigamonti","year":"2001","unstructured":"Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, Cattaneo E (2001) Huntingtin\u2019s neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276:14545\u201314548. https:\/\/doi.org\/10.1074\/jbc.C100044200","journal-title":"J Biol Chem"},{"key":"9989_CR216","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"9989_CR217","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.neuint.2011.04.009","volume":"59","author":"TR Rosenstock","year":"2011","unstructured":"Rosenstock TR, de Brito OM, Lombardi V, Louros S, Ribeiro M, Almeida S, Ferreira IL, Oliveira CR, Rego AC (2011) FK506 ameliorates cell death features in Huntington\u2019s disease striatal cell models. Neurochem Int 59:600\u2013609. https:\/\/doi.org\/10.1016\/j.neuint.2011.04.009","journal-title":"Neurochem Int"},{"key":"9989_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006549","volume":"5","author":"DC Rubinsztein","year":"2003","unstructured":"Rubinsztein DC, Carmichael J (2003) Huntington\u2019s disease: molecular basis of neurodegeneration. Expert Rev Mol Med 5:1\u201321. https:\/\/doi.org\/10.1017\/S1462399403006549","journal-title":"Expert Rev Mol Med"},{"key":"9989_CR219","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2016.11.050","volume":"107","author":"M Saki","year":"2017","unstructured":"Saki M, Prakash A (2017) DNA damage related crosstalk between the nucleus and mitochondria. Free Radic Biol Med 107:216\u2013227. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.11.050","journal-title":"Free Radic Biol Med"},{"key":"9989_CR220","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","volume":"1830","author":"Y Samuni","year":"2013","unstructured":"Samuni Y, Goldstein S, Dean OM, Berk M (2013) The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830:4117\u20134129. https:\/\/doi.org\/10.1016\/j.bbagen.2013.04.016","journal-title":"Biochim Biophys Acta"},{"key":"9989_CR221","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000334273","volume":"9","author":"R Sandhir","year":"2012","unstructured":"Sandhir R, Sood A, Mehrotra A, Kamboj SS (2012) N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegener Dis 9:145\u2013157. https:\/\/doi.org\/10.1159\/000334273","journal-title":"Neurodegener Dis"},{"key":"9989_CR222","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1471-4159.2003.01857.x","volume":"86","author":"A Santamar\u00eda","year":"2003","unstructured":"Santamar\u00eda A, Salvatierra-S\u00e1nchez R, V\u00e1zquez-Rom\u00e1n B, Santiago-L\u00f3pez D, Villeda-Hern\u00e1ndez J, Galv\u00e1n-Arzate S, Jim\u00e9nez-Capdeville ME, Ali SF (2003) Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem 86:479\u2013488","journal-title":"J Neurochem"},{"key":"9989_CR223","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Greenamyre JT, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194\u20131198. https:\/\/doi.org\/10.1038\/13518","journal-title":"Nat Med"},{"key":"9989_CR224","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"9989_CR225","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","volume":"315","author":"G Schilling","year":"2001","unstructured":"Schilling G, Coonfield ML, Ross CA, Borchelt DR (2001) Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington\u2019s disease transgenic mouse model. Neurosci Lett 315:149\u2013153","journal-title":"Neurosci Lett"},{"key":"9989_CR226","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","volume":"273","author":"KF Schulz","year":"1995","unstructured":"Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408\u2013412","journal-title":"JAMA"},{"key":"9989_CR227","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/14737175.2015.1025383","volume":"15","author":"LC Schwab","year":"2015","unstructured":"Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA (2015) Dopamine and Huntington\u2019s disease. Expert Rev Neurother 15:445\u2013458. https:\/\/doi.org\/10.1586\/14737175.2015.1025383","journal-title":"Expert Rev Neurother"},{"key":"9989_CR228","first-page":"16","volume":"9","author":"EM Scrimgeour","year":"2009","unstructured":"Scrimgeour EM (2009) Huntington disease (chorea) in the Middle East. Sultan Qaboos Univ Med J 9:16\u201323","journal-title":"Sultan Qaboos Univ Med J"},{"key":"9989_CR229","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","volume":"11","author":"DA Shear","year":"2000","unstructured":"Shear DA, Haik KL, Dunbar GL (2000) Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 11:1833\u20131837","journal-title":"Neuroreport"},{"key":"9989_CR230","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012. https:\/\/doi.org\/10.1083\/jcb.200508072","journal-title":"J Cell Biol"},{"key":"9989_CR231","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455. https:\/\/doi.org\/10.1093\/hmg\/ddr024","journal-title":"Hum Mol Genet"},{"key":"9989_CR232","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000443896","volume":"97","author":"S Singh","year":"2016","unstructured":"Singh S, Kumar P (2016) Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats. Pharmacology 97:151\u2013160. https:\/\/doi.org\/10.1159\/000443896","journal-title":"Pharmacology"},{"key":"9989_CR233","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","volume":"11","author":"S Sipione","year":"2002","unstructured":"Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, Pritchard J, Kooperberg C, Olson JM, Cattaneo E (2002) Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 11:1953\u20131965","journal-title":"Hum Mol Genet"},{"key":"9989_CR234","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"9989_CR235","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1471-4159.2007.04703.x","volume":"103","author":"R Smith","year":"2007","unstructured":"Smith R, Klein P, Koc-Schmitz Y, Waldvogel HJ, Faull RLM, Brundin P, Plomann M, Li JY (2007) Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington\u2019s disease. J Neurochem 103:115\u2013123. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04703.x","journal-title":"J Neurochem"},{"key":"9989_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2015.09.003","volume":"153","author":"ND Solovyev","year":"2015","unstructured":"Solovyev ND (2015) Importance of selenium and selenoprotein for brain function: from antioxidant protection to neuronal signalling. J Inorg Biochem 153:1\u201312. https:\/\/doi.org\/10.1016\/j.jinorgbio.2015.09.003","journal-title":"J Inorg Biochem"},{"key":"9989_CR237","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0166-2236(02)02270-1","volume":"25","author":"I Song","year":"2002","unstructured":"Song I, Huganir RL (2002) Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25:578\u2013588","journal-title":"Trends Neurosci"},{"key":"9989_CR238","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR, Masliah E, Ellisman M, Rouiller I, Schwarzenbacher R, Bossy B, Perkins G, Bossy-Wetzel E (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377\u2013382. https:\/\/doi.org\/10.1038\/nm.2313","journal-title":"Nat Med"},{"key":"9989_CR239","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","volume":"45","author":"MA Sorolla","year":"2008","unstructured":"Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 45:667\u2013678. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.05.014","journal-title":"Free Radic Biol Med"},{"key":"9989_CR240","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","volume":"49","author":"MA Sorolla","year":"2010","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Tamarit J, Ortega Z, Lucas JJ, Ferrer I, Ros J, Cabiscol E (2010) Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic Biol Med 49:612\u2013621. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.05.016","journal-title":"Free Radic Biol Med"},{"key":"9989_CR241","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4:49\u201360. https:\/\/doi.org\/10.1038\/nrn1007","journal-title":"Nat Rev Neurosci"},{"key":"9989_CR242","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri F, Cannella M, Sgarbi G, Maglione V, Falleni A, Lenzi P, Baracca A, Cislaghi G, Saft C, Ragona G, Russo MA, Thompson LM, Solaini G, Fornai F (2006) Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 127:217\u2013220. https:\/\/doi.org\/10.1016\/j.mad.2005.09.010","journal-title":"Mech Ageing Dev"},{"key":"9989_CR243","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ (2005) Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice. J Comp Neurol 490:354\u2013370. https:\/\/doi.org\/10.1002\/cne.20680","journal-title":"J Comp Neurol"},{"key":"9989_CR244","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","volume":"49","author":"C Stack","year":"2010","unstructured":"Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M, Beal MF (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington\u2019s disease. Free Radic Biol Med 49:147\u2013158. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.03.017","journal-title":"Free Radic Biol Med"},{"key":"9989_CR245","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1212\/WNL.24.9.813","volume":"24","author":"WL Stahl","year":"1974","unstructured":"Stahl WL, Swanson PD (1974) Biochemical abnormalities in Huntington\u2019s chorea brains. Neurology 24:813\u2013819","journal-title":"Neurology"},{"issue":"1","key":"9989_CR246","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1550-2783-11-11","volume":"11","author":"GP Stefani","year":"2014","unstructured":"Stefani GP, Nunes RB, Dornelles AZ, Alves JP, Piva MO, Domenico MD, Rhoden CR, Lago PD (2014) Effects of creatine supplementation associated with resistance training on oxidative stress in different tissues of rats. J Int Soc Sports Nutr 11(1):11. https:\/\/doi.org\/10.1186\/1550-2783-11-11","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"9989_CR247","first-page":"1080","volume":"4","author":"SN Suganya","year":"2014","unstructured":"Suganya SN, Sumathi T (2014) Rutin attenuates 3-nitropropionic acid induced behavioural alterations and mitochondrial dysfunction in the striatum of rat brain. World J Pharm Pharm Sci 4(1):1080\u20131092","journal-title":"World J Pharm Pharm Sci"},{"key":"9989_CR248","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","volume":"32","author":"SN Suganya","year":"2017","unstructured":"Suganya SN, Sumathi T (2017) Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington\u2019s disease model in rats. Metab Brain Dis 32:471\u2013481. https:\/\/doi.org\/10.1007\/s11011-016-9929-4","journal-title":"Metab Brain Dis"},{"key":"9989_CR249","first-page":"336","volume":"59","author":"N Suh","year":"1999","unstructured":"Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K, Sporn MB (1999) A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res 59:336\u2013341","journal-title":"Cancer Res"},{"key":"9989_CR250","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.expneurol.2003.08.016","volume":"184","author":"Z Sun","year":"2003","unstructured":"Sun Z, Chen Q, Reiner A (2003) Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age. Exp Neurol 184:1034\u20131042. https:\/\/doi.org\/10.1016\/j.expneurol.2003.08.016","journal-title":"Exp Neurol"},{"key":"9989_CR251","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","volume":"40","author":"G Szebenyi","year":"2003","unstructured":"Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, Young M, Faber PW, MacDonald ME, McPhaul MJ, Brady ST (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41\u201352","journal-title":"Neuron"},{"key":"9989_CR252","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"9989_CR253","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1212\/01.WNL.0000070186.97463.A7","volume":"61","author":"SJ Tabrizi","year":"2003","unstructured":"Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AHV, Warner TT (2003) Creatine therapy for Huntington\u2019s disease: clinical and MRS findings in a 1-year pilot study. Neurology 61:141\u2013142","journal-title":"Neurology"},{"key":"9989_CR254","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1212\/01.WNL.0000160388.96242.77","volume":"64","author":"SJ Tabrizi","year":"2005","unstructured":"Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AHV, Warner TT (2005) High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study. Neurology 64:1655\u20131656. https:\/\/doi.org\/10.1212\/01.WNL.0000160388.96242.77","journal-title":"Neurology"},{"key":"9989_CR255","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","volume":"27","author":"TS Tang","year":"2007","unstructured":"Tang TS, Chen X, Liu J, Bezprozvanny I (2007) Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease. J Neurosci 27:7899\u20137910. https:\/\/doi.org\/10.1523\/JNEUROSCI.1396-07.2007","journal-title":"J Neurosci"},{"key":"9989_CR256","doi-asserted-by":"publisher","unstructured":"Tapia E, Soto V, Ortiz-Vega KM, Zarco-M\u00e1rquez G, Molina-Jij\u00f3n E, Crist\u00f3bal-Garc\u00eda M, Santamar\u00eda J, Garc\u00eda-Ni\u00f1o WR, Correa F, Zazueta C, Pedraza-Chaverri J (2012) Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5\/6 nephrectomized rats. Oxidative Med Cell Longev 2012. https:\/\/doi.org\/10.1155\/2012\/269039","DOI":"10.1155\/2012\/269039"},{"key":"9989_CR257","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.1028","volume":"49","author":"MA Tarnopolsky","year":"2001","unstructured":"Tarnopolsky MA, Beal MF (2001) Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 49:561\u2013574","journal-title":"Ann Neurol"},{"key":"9989_CR258","first-page":"424","volume":"49","author":"I Tasset","year":"2009","unstructured":"Tasset I, S\u00e1nchez F, T\u00fanez I (2009) The molecular bases of Huntington\u2019s disease: the role played by oxidative stress. Rev Neurol 49:424\u2013429","journal-title":"Rev Neurol"},{"key":"9989_CR259","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/00005072-197404000-00008","volume":"33","author":"I Tellez-Nagel","year":"1974","unstructured":"Tellez-Nagel I, Johnson AB, Terry RD (1974) Studies on brain biopsies of patients with Huntington\u2019s chorea. J Neuropathol Exp Neurol 33:308\u2013332","journal-title":"J Neuropathol Exp Neurol"},{"key":"9989_CR260","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9989_CR261","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bbrc.2006.10.102","volume":"351","author":"RK Thimmulappa","year":"2006","unstructured":"Thimmulappa RK, Scollick C, Traore K, Yates M, Trush MA, Liby KT, Sporn MB, Yamamoto M, Kensler TW, Biswal S (2006) Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem Biophys Res Commun 351:883\u2013889. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.102","journal-title":"Biochem Biophys Res Commun"},{"key":"9989_CR262","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/brain\/awq047","volume":"133","author":"DCV Thu","year":"2010","unstructured":"Thu DCV, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RLM (2010) Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease. Brain 133:1094\u20131110. https:\/\/doi.org\/10.1093\/brain\/awq047","journal-title":"Brain"},{"key":"9989_CR263","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","volume":"145","author":"E Trushina","year":"2007","unstructured":"Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145:1233\u20131248. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.10.056","journal-title":"Neuroscience"},{"key":"9989_CR264","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195\u20138209. https:\/\/doi.org\/10.1128\/MCB.24.18.8195-8209.2004","journal-title":"Mol Cell Biol"},{"key":"9989_CR265","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","volume":"37","author":"I T\u00fanez","year":"2004","unstructured":"T\u00fanez I, Montilla P, Del Carmen Mu\u00f1oz M, Feij\u00f3o M, Salcedo M (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease. J Pineal Res 37:252\u2013256. https:\/\/doi.org\/10.1111\/j.1600-079X.2004.00163.x","journal-title":"J Pineal Res"},{"key":"9989_CR266","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1021\/jm200605a","volume":"54","author":"I T\u00fanez","year":"2011","unstructured":"T\u00fanez I, S\u00e1nchez-L\u00f3pez F, Ag\u00fcera E, Fern\u00e1ndez-Bola\u00f1os R, S\u00e1nchez FM, Tasset-Cuevas I (2011) Important role of oxidative stress biomarkers in Huntington\u2019s disease. J Med Chem 54:5602\u20135606. https:\/\/doi.org\/10.1021\/jm200605a","journal-title":"J Med Chem"},{"key":"9989_CR267","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0952-3278(92)90062-N","volume":"46","author":"KS Vaddadi","year":"1992","unstructured":"Vaddadi KS (1992) Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia. Prostaglandins Leukot Essent Fatty Acids 46:67\u201370","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"9989_CR268","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00001756-200201210-00011","volume":"13","author":"KS Vaddadi","year":"2002","unstructured":"Vaddadi KS, Soosai E, Chiu E, Dingjan P (2002) A randomised, placebo-controlled, double blind study of treatment of Huntington\u2019s disease with unsaturated fatty acids. NeuroReport 13:29","journal-title":"NeuroReport"},{"key":"9989_CR269","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E Duijn van","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19:441\u2013448. https:\/\/doi.org\/10.1176\/jnp.2007.19.4.441","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9989_CR270","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","volume":"14","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, Leavitt BR (2005) Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14:1379\u20131392. https:\/\/doi.org\/10.1093\/hmg\/ddi147","journal-title":"Hum Mol Genet"},{"key":"9989_CR271","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","volume":"61","author":"P Verbessem","year":"2003","unstructured":"Verbessem P, Lemiere J, Eijnde BO, Swinnen S, Vanhees L, Van Leemputte M, Hespel P, Dom R (2003) Creatine supplementation in Huntington\u2019s disease: a placebo-controlled pilot trial. Neurology 61:925\u2013930","journal-title":"Neurology"},{"key":"9989_CR272","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/hmg\/ddg075","volume":"12","author":"S H\u00f6rsten von","year":"2003","unstructured":"von H\u00f6rsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AMM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O (2003) Transgenic rat model of Huntington\u2019s disease. Hum Mol Genet 12:617\u2013624","journal-title":"Hum Mol Genet"},{"key":"9989_CR273","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"9989_CR274","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/exnr.1994.1081","volume":"127","author":"MV Wagster","year":"1994","unstructured":"Wagster MV, Hedreen JC, Peyser CE, Folstein SE, Ross CA (1994) Selective loss of [3H] kainic acid and [3H] AMPA binding in layer VI of frontal cortex in Huntington\u2019s disease. Exp Neurol 127:70\u201375. https:\/\/doi.org\/10.1006\/exnr.1994.1081","journal-title":"Exp Neurol"},{"key":"9989_CR275","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007a) Huntington\u2019s disease. Lancet 369:218\u2013228. https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"key":"9989_CR276","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007b) Huntington\u2019s disease. Lancet 369:218\u2013228. https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"key":"9989_CR277","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00210-009-0470-4","volume":"381","author":"CJ Wang","year":"2010","unstructured":"Wang CJ, Hu CP, Xu KP, Yuan Q, Li FS, Zou H, Tan GS, Li YJ (2010) Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedeberg's Arch Pharmacol 381:73\u201381. https:\/\/doi.org\/10.1007\/s00210-009-0470-4","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"9989_CR278","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"147","author":"X Wang","year":"2011","unstructured":"Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147:893\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2011.10.018","journal-title":"Cell"},{"key":"9989_CR279","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-8993(99)02433-6","volume":"858","author":"JX Wilson","year":"2000","unstructured":"Wilson JX, Peters CE, Sitar SM, Daoust P, Gelb AW (2000) Glutamate stimulates ascorbate transport by astrocytes. Brain Res 858:61\u201366","journal-title":"Brain Res"},{"key":"9989_CR280","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/ja053679l","volume":"127","author":"P Wipf","year":"2005","unstructured":"Wipf P, Xiao J, Jiang J, Belikova NA, Tyurin VA, Fink MP, Kagan VE (2005) Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J Am Chem Soc 127:12460\u201312461. https:\/\/doi.org\/10.1021\/ja053679l","journal-title":"J Am Chem Soc"},{"key":"9989_CR281","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/hmg\/5.4.481","volume":"5","author":"JD Wood","year":"1996","unstructured":"Wood JD, MacMillan JC, Harper PS, Lowenstein PR, Jones AL (1996) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human. Mouse and Rat Brain Hum Mol Genet 5:481\u2013487. https:\/\/doi.org\/10.1093\/hmg\/5.4.481","journal-title":"Mouse and Rat Brain Hum Mol Genet"},{"key":"9989_CR282","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddw077","volume":"25","author":"DJ Wright","year":"2016","unstructured":"Wright DJ, Gray LJ, Finkelstein DI, Crouch PJ, Pow D, Pang TY, Li S, Smith ZM, Francis PS, Renoir T, Hannan AJ (2016) N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease. Hum Mol Genet 25:2923\u20132933. https:\/\/doi.org\/10.1093\/hmg\/ddw144","journal-title":"Hum Mol Genet"},{"key":"9989_CR283","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","volume":"11","author":"A Wyttenbach","year":"2002","unstructured":"Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11:1137\u20131151","journal-title":"Hum Mol Genet"},{"key":"9989_CR284","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","volume":"2","author":"Z Xun","year":"2012","unstructured":"Xun Z, Rivera-S\u00e1nchez S, Ayala-Pe\u00f1a S, Lim J, Budworth H, Skoda EM, Robbins PD, Niedernhofer LJ, Wipf P, McMurray CT (2012) Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease. Cell Rep 2:1137\u20131142. https:\/\/doi.org\/10.1016\/j.celrep.2012.10.001","journal-title":"Cell Rep"},{"key":"9989_CR285","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF (2009) Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 109:1427\u20131439. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06074.x","journal-title":"J Neurochem"},{"key":"9989_CR286","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/1535-7163.MCT-06-0516","volume":"6","author":"MS Yates","year":"2007","unstructured":"Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T, Gribble GW, Johnson DA, Johnson JA, Burton NC, Guilarte TR, Yamamoto M, Sporn MB, Kensler TW (2007) Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther 6:154\u2013162. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0516","journal-title":"Mol Cancer Ther"},{"key":"9989_CR287","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.2841762","volume":"241","author":"AB Young","year":"1988","unstructured":"Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D\u2019Amato C, Shoulson I, Penney JB (1988) NMDA receptor losses in putamen from patients with Huntington\u2019s disease. Science 241:981\u2013983","journal-title":"Science"},{"key":"9989_CR288","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","volume":"100","author":"JM Young","year":"2007","unstructured":"Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS (2007) Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol 100:1400\u20131403. https:\/\/doi.org\/10.1016\/j.amjcard.2007.06.03","journal-title":"Am J Cardiol"},{"key":"9989_CR289","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","volume":"25","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Leavitt BR, van Raamsdonk JM, Dragatsis I, Goldowitz D, MacDonald ME, Hayden MR, Friedlander RM (2006) Huntingtin inhibits caspase-3 activation. EMBO J 25:5896\u20135906. https:\/\/doi.org\/10.1038\/sj.emboj.7601445","journal-title":"EMBO J"},{"key":"9989_CR290","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pneurobio.2012.09.003","volume":"100","author":"M Zhang","year":"2013","unstructured":"Zhang M, An C, Gao Y, Leak RK, Chen J, Zhang F (2013) Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol 100:30\u201347. https:\/\/doi.org\/10.1016\/j.pneurobio.2012.09.003","journal-title":"Prog Neurobiol"},{"key":"9989_CR291","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.01.003","journal-title":"Prog Neurobiol"},{"key":"9989_CR292","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383. https:\/\/doi.org\/10.1038\/ng1219","journal-title":"Nat Genet"},{"key":"9989_CR293","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981. https:\/\/doi.org\/10.1152\/physrev.00041.2009","journal-title":"Physiol Rev"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-018-9989-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T07:30:26Z","timestamp":1606030226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-018-9989-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":293,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["9989"],"URL":"https:\/\/doi.org\/10.1007\/s12640-018-9989-9","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"22 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}